13F-HR filed by Sands Capital Alternatives, LLC
Sands Capital Alternatives, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-13, with 24 holding rows worth $365,127,000.
- Accession
- 0001846444-23-000001
- Filer
- CIK 1846444
- Filed
- 2023-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 24 entries on the cover page, a total value of $365,127,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $365,127,000 with VALUE read as thousands, detected and multiplied, 13F file number 028-21032. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DICE THERAPEUTICS INC | 23345J104 | COM | 2,748,970 | $85,768,000 | thousands, detected and multiplied | |
| UIPATH INC | 90364P105 | CL A | 3,816,569 | $48,509,000 | thousands, detected and multiplied | |
| NU HLDGS LTD | G6683N103 | ORD SHS CL A | 9,156,347 | $37,266,000 | thousands, detected and multiplied | |
| SAMSARA, INC. | FDS1Q2O30 | COM CL B | 2,712,256 | $33,713,000 | thousands, detected and multiplied | |
| SNOWFLAKE INC COM SHS | 833445109 | Stock | 215,535 | $30,938,000 | thousands, detected and multiplied | |
| DOORDASH INC CL A | 25809K105 | Stock | 603,512 | $29,463,000 | thousands, detected and multiplied | |
| ACRIVON THERAPEUTICS INC | 004890109 | CMN | 1,652,605 | $19,038,000 | thousands, detected and multiplied | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 3,417,075 | $18,452,000 | thousands, detected and multiplied | |
| OLINK HLDG AB | 680710100 | ADR | 705,514 | $17,906,000 | thousands, detected and multiplied | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 481,770 | $17,556,000 | thousands, detected and multiplied | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 58,895 | $11,573,000 | thousands, detected and multiplied | |
| SAMSARA INC COM CL A | 79589L106 | Stock | 332,520 | $4,133,000 | thousands, detected and multiplied | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 260,000 | $3,812,000 | thousands, detected and multiplied | |
| 908 DEVICES INC COM | 65443P102 | Stock | 326,427 | $2,487,000 | thousands, detected and multiplied | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 724,873 | $1,638,000 | thousands, detected and multiplied | |
| CANDEL THERAPEUTICS INC | 137404109 | COMMON STOCK | 811,737 | $1,453,000 | thousands, detected and multiplied | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 787,007 | $866,000 | thousands, detected and multiplied | |
| ABSCI CORPORATION | 00091E109 | COM | 57,804 | $121,000 | thousands, detected and multiplied | |
| COUPANG INC | 22266T109 | CL A | 6,971 | $103,000 | thousands, detected and multiplied | |
| DATADOGINCCLASSA | 23804L103 | STOK | 1,366 | $100,000 | thousands, detected and multiplied | |
| CROWDSTRIKE HLDGS INC | 22788C105 | COM | 864 | $91,000 | thousands, detected and multiplied | |
| TOASTINCCLASSCLASSA | 888787108 | STOK | 4,494 | $81,000 | thousands, detected and multiplied | |
| GITLAB INC CLASS A COM | 37637K108 | Stock | 658 | $30,000 | thousands, detected and multiplied | |
| CONFLUENT INC | 20717M103 | CLASS A COM | 1,354 | $30,000 | thousands, detected and multiplied |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001846444-23-000001 | this filing | 2023-02-13 | acceptance time not in the bulk data set |